TY  - JOUR
AU  - Jecmenica Lukic, Milica
AU  - Kurz, Carolin
AU  - Respondek, Gesine
AU  - Grau-Rivera, Oriol
AU  - Compta, Yaroslau
AU  - Gelpi, Ellen
AU  - Troakes, Claire
AU  - Barcelona Brain Bank collaborative group, the MDS-endorsed PSP study group
AU  - van Swieten, John C
AU  - Giese, Armin
AU  - Roeber, Sigrun
AU  - Arzberger, Thomas
AU  - Höglinger, Günter
AU  - Grau-Rivera, O.
AU  - Compta, Y.
AU  - Tolosa, E.
AU  - Martí, M. J.
AU  - Valldeoriola, F.
AU  - Pagonabarraga, J.
AU  - Calopa, M.
AU  - Bayès, A.
AU  - Hernandez, I.
AU  - Aguilar, M.
AU  - Genis, D.
AU  - Fernandez, M.
AU  - Munoz-Garcia, C.
AU  - Antonell, A.
AU  - Gelpi, E.
TI  - Copathology in Progressive Supranuclear Palsy: Does It Matter?
JO  - Movement disorders
VL  - 35
IS  - 6
SN  - 1531-8257
CY  - New York, NY
PB  - Wiley
M1  - DZNE-2020-01336
SP  - 984 - 993
PY  - 2020
AB  - The influence of concomitant brain pathologies on the progression rate in PSP is unclear.To analyze the frequency and severity of copathologies and their impact on the progression in PSP.We analyzed clinic-pathological features of 101 PSP patients. Diagnoses and stages of copathologies were established according to standardized criteria, including Alzheimer's disease-related pathology, argyrophilic grains, Lewy-related pathology, transactive response DNA-binding protein 43 pathology, fused in sarcoma pathology, cerebral amyloid angiopathy, and small vessel disease. Demographic data and major clinical milestones (frequency and latency to onset) were extracted from patients' files.Only 8
KW  - Alzheimer Disease: epidemiology
KW  - Brain: metabolism
KW  - Humans
KW  - Movement Disorders
KW  - Supranuclear Palsy, Progressive: epidemiology
KW  - tau Proteins: metabolism
LB  - PUB:(DE-HGF)16
C6  - pmid:32125724
DO  - DOI:10.1002/mds.28011
UR  - https://pub.dzne.de/record/153339
ER  -